Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name MIAT
   Synonyms MIAT, C22orf35, GOMAFU, LINC00066, NCRNA00066, RNCR2, lncRNA-MIAT, FLJ25967
   Region GRCh38_22:26646428-26676475    Sequence
   Ensembl ENSG00000225783
   RefSeq NR_003491
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name chronic lymphocytic leukemia
   ICD-0-3  M9823/3
   Methods qPCR, RNAi, Western blot, Cell proliferation assay etc.
   Sample CLL tissues, leukemia/lymphoma cell lines
   Expression Pattern up-regulated
   Function Description

MIAT expression was upregulated in breast cancer cell lines and tissues.MIAT acted as a competing endogenous RNA (ceRNA) to regulate the expression of dual specificity phosphatase 7 (DUSP7) by taking up miR-155-5p in breast cancer. There were positive correlation between MIAT and DUSP7 expression in breast cancer patients.MIAT promotes breast cancer progression and functions as ceRNA to regulate DUSP7 expression by sponging miR-155-5p in breast cancer. MIAT was specifically up-regulated in the plasma and aqueous humor of cataract patients.

   Pubmed ID 27527866
   Year 2016
   Title Upregulation of long noncoding RNA MIAT in aggressive form of chronic lymphocytic leukemias.
   External Links
   Links for  MIAT GenBank       HGNC       lncrnadb       Noncode
   Links for  chronic lymphocytic leukemia Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.